# Medical Optimization of Management of Type 2 Diabetes Complicating Pregnancy (MOMPOD)

> **NCT02932475** · PHASE3 · TERMINATED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 831 (actual)

## Conditions studied

- Diabetes
- Pregnancy

## Interventions

- **DRUG:** Metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02932475
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-05-25
- **Primary completion:** 2022-06-15
- **Final completion:** 2022-06-15
- **Target enrollment:** 831 (ACTUAL)
- **Why stopped:** Recommendation by the DSMB that the study be stopped for futility
- **Last updated:** 2023-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02932475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02932475, "Medical Optimization of Management of Type 2 Diabetes Complicating Pregnancy (MOMPOD)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02932475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*